NCT00595543已完成4 期
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 166
- 试验地点
- 1
- 主要终点
- Acute Pseudophakic Cystoid Macular Edema
研究概览
简要总结
To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must be diagnosed with acute pseudophakic CME within 12 months of cataract surgery
- •Males and females 18 years and older
- •Able to provide written informed consent
排除标准
- •Complicated cataract surgery, particularly posterior capsule rupture and vitreous loss
- •Pre-Existing macular pathology, including macular edema, macular scar, macular hole, or macular pucker
- •History of Uveitis
- •Ipsilateral intraocular surgery prior to cataract surgery
- •CME greater than one year duration
研究组 & 干预措施
1
Active Comparator
干预措施: Bromfenac (Drug)
2
Active Comparator
干预措施: Ketorolac (Drug)
3
Active Comparator
干预措施: Diclofenac (Drug)
结局指标
主要结局
Acute Pseudophakic Cystoid Macular Edema
时间窗: 5 months
次要结局
- Visual Acuity(5 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction PhaseDry Eye DiseaseOcular ComfortNCT00520260Florida Eye Microsurgical Institute42
已完成
1 期
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone AcetonideCYSTOID MACULAR EDEMANCT02294656Soll Eye4
已完成
4 期
Bromfenac Versus Dexamethasone After Cataract SurgeryInflammation EyeNCT03317847Azienda USL Reggio Emilia - IRCCS92
已完成
不适用
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive KeratectomyMyopiaNCT01475877Virdi Eye Clinic20
已完成
不适用
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus PlaceboCystoid Macular EdemaNCT03025945Intuor Technologies, Inc.662